Claro Advisors LLC Merck & Co., Inc. Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Claro Advisors LLC holds 18,385 shares of MRK stock, worth $1.82 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

18,385

Previous 17,586 4.54%

Holding current value

$1.82 Million

Previous $2 Million 4.51%

% of portfolio

0.3%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$111.15 - $128.97 $88,808 - $103,047	799 Added 4.54%	18,385 $2.09 Million
Q3 2024 Oct 17, 2024	BUY	$111.15 - $128.97 $146,273 - $169,724	1,316 Added 8.09%	17,586 $2 Million
Q2 2024 Jul 31, 2024	BUY	$123.8 - $132.96 $202,165 - $217,123	1,633 Added 11.16%	16,270 $2.01 Million
Q1 2024 Apr 18, 2024	BUY	$113.24 - $131.95 $71,907 - $83,788	635 Added 4.54%	14,637 $1.93 Million
Q4 2023 Jan 22, 2024	BUY	$100.18 - $109.02 $54,097 - $58,870	540 Added 4.01%	14,002 $1.53 Million
Q3 2023 Oct 10, 2023	BUY	$102.95 - $114.33 $34,591 - $38,414	336 Added 2.56%	13,462 $1.39 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $47,897 - $52,205	441 Added 3.48%	13,126 $1.51 Million
Q1 2023 Apr 17, 2023	BUY	$102.94 - $114.86 $199,600 - $222,713	1,939 Added 18.04%	12,685 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $217,550 - $278,929	2,488 Added 30.13%	10,746 $1.19 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $42,663 - $48,361	511 Added 6.6%	8,258 $753,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $7,661 - $9,597	106 Added 1.39%	7,747 $594,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $24,227 - $26,644	338 Added 4.63%	7,641 $574,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $43,803 - $48,450	623 Added 9.33%	7,303 $568,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $8,607 - $10,138	125 Added 1.91%	6,680 $515,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $130,549 - $144,883	-1,819 Reduced 21.72%	6,555 $536,000
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $951 - $1,078	13 Added 0.16%	8,374 $695,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $4,858 - $5,528	69 Added 0.83%	8,361 $647,000
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $89,907 - $124,616	-1,419 Reduced 14.61%	8,292 $638,000
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $12,567 - $14,181	162 Added 1.7%	9,711 $883,000
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $2,130 - $2,322	28 Added 0.29%	9,549 $804,000
Q2 2019 Jul 24, 2019	BUY	$69.84 - $81.59 $4,260 - $4,976	61 Added 0.64%	9,521 $798,000
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $512,108 - $584,089	7,360 Added 350.48%	9,460 $787,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $137,004 - $158,991	2,100 New	2,100 $149,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Merck & Co., Inc. Transaction History